INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 74 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $30,000 | -26.8% | 31,174 | +42.3% | 0.00% | -50.0% |
| Q1 2019 | $41,000 | -83.0% | 21,910 | -87.9% | 0.00% | -83.3% |
| Q3 2017 | $241,000 | +69.7% | 181,220 | +99.8% | 0.01% | +50.0% |
| Q2 2017 | $142,000 | +373.3% | 90,720 | +367.6% | 0.01% | -20.0% |
| Q3 2016 | $30,000 | -85.7% | 19,400 | -87.8% | 0.01% | 0.0% |
| Q2 2016 | $210,000 | -89.4% | 158,507 | -12.4% | 0.01% | -84.8% |
| Q2 2015 | $1,981,000 | +607.5% | 180,925 | +766.6% | 0.07% | +407.7% |
| Q3 2014 | $280,000 | -53.7% | 20,877 | -52.4% | 0.01% | -59.4% |
| Q4 2013 | $605,000 | -91.2% | 43,866 | -89.6% | 0.03% | -85.7% |
| Q2 2013 | $6,849,000 | – | 423,079 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
| Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
| Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
| PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
| Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
| ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |